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LEVELS OF NITRIC OXIDE METABOLITES IN RATS 
WITH HEPATOPULMONARY SYNDROME 
I. Ya. Krynytska
I. HORBACHEVSKY TERNOPIL STATE MEDICAL UNIVERSITY, TERNOPIL, UKRAINE
Background. System of nitric oxide (NO), which consists of NO, and its metabolites, is very important for 
various biological processes. NO is signalling molecules and mediators of intracellular and intercellular interaction 
that causes relaxation of smooth muscles of blood vessel walls, inhibits platelet aggregation and their adherence, 
is involved in the transmission of nerve impulses, cell proliferation.
Objective. The aim of our research was to study the content of nitric oxide metabolites in blood serum and 
bronchoalveolar lavage, to substantiate their role in pathogenesis of hepatopulmonary syndrome in 
experiment.
Methods. The experiments were performed on 56 outbread male rats, 180-220 g in weight. The first ex-
perimental model of hepatopulmonary syndrome (HPS) was made by imposition of double ligature on common 
bile duct and its further dissection with a scalpel. The second experimental HPS model was made by 8-week in-
tragastric administration of oil solution CCl4 (400 g per 1 L), 0.5 ml per 100 g of body weight on the first day of 
the experiment, 0.3 ml per 100 g on the third day of the experiment and then every third day until the end of the 
experiment 0.3 ml per 100 g. A mixture of corn flour, lard and cholesterol and alcohol solution was added to the 
standard diet of the rats.
Results. The total content of nitric oxide metabolites in blood serum of the rats of the experimental group 
No.1 (on the 31st day after the common bile duct ligation) was significantly increased in 3.9 times (p1<0,001) if 
compared with the control group №1. In the rats of the 2nd experimental group (with carbon tetrachloride induced 
cirrhosis) the total content of nitric oxide metabolites in blood serum also significantly increased in 3.1 times 
(p1<0,001). Comparison of nitric oxide metabolites content in blood serum and bronchoalveolar lavage, which 
directly indicated about the processes in lung tissue, was great importance.
Conclusions. So, in rats with experimental hepatopulmonary syndrome activation of nitroxydergic process 
by significant increase in nitric oxide metabolites in blood serum and bronchoalveolar lavage took place.
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Introduction 
System of nitric oxide (NO), which consists 
of NO, and its metabolites, is very important for 
various biological processes [2]. NO is signalling 
molecules and mediators of intracellular and 
intercellular interaction that causes relaxation 
of smooth muscles of blood vessel walls, inhi­
bits platelet aggregation and their adherence, 
is involved in the transmission of nerve im­
pulses, cell proliferation. Cytostatic activity is 
also presented in NO. Formation of this agent 
by immunocompetent cells provides protection 
of body from being infected by bacteria and 
cancer cells. The researches on participation of 
NO in the process of apoptosis are very inte­
resting [1, 5, 10]. Contemporary studies on 
pulmonary disorders are also associated with 
impaired nitroxidergic dysfunction [3, 7].
NO is a molecule of high reactivity with an 
effective half­life from 2 to 30 sec, which is 
formed by the enzymatic oxidation of L­arginine 
under the influence of cytochrome P-450-like 
hemoproteins – NO­synthase (NOS). There are 
3 isoforms of this enzyme, endothelial (eNOS), 
neuronal (nNOS) or brain and inducible (iNOS) 
or macrophagal [4, 6]. As a lipophilic molecule, 
NO easily diffuses through cell membranes into 
the neighbouring cells (e.g. from endothelial 
to myocytes of vessels) where the formed cyclic 
guanosine monophosphate decreases the level 
of free calcium and activates the kinase of myo-
sin light chain causing dilatation of vessel [4].
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Most cytotoxic effects of NO belong to 
ONOO that is formed in reaction with superoxide. 
Peroxynitrite is much more active, nitrosates 
proteins intensively and can be a source of a 
highly toxic hydroxyl radical in reaction with 
superoxide anion radical. ONOO- irreversibly 
inhibits enzymes of respiratory chain nitrosating 
them and taking iron away. Inhibition of mito-
chondrial respiration can cause apoptosis [9].
Production of NO by alveoli can influence 
the hemodynamic and gas exchange in patients 
with liver cirrhosis. Thus, a direct relationship 
between alveolar products of NO and hyper-
dynamic type of circulation was established 
[12]. Moreover, in experimental liver cirrhosis 
in rats, hyper-expression of both inducible and 
constitutional isoforms of NO were observed – 
synthase in alveolar macrophages and lung 
endothelial cells [22].
The average life span of nitric oxide in the 
body is a few seconds. Nitric oxide, which did 
not participate in chemical reactions, is rapidly 
oxidized to inactive compounds: nitrites and 
nitrates. These are nitric oxide stable meta-
bolites, which are the method of this compound 
synthesis intensity evaluation [18].
So, the aim of our research was to study the 
content of nitric oxide metabolites in blood se-
rum and bronchoalveolar lavage, to substantiate 
their role in pathogenesis of hepatopulmonary 
syndrome in experiment.
Material and Methods
The experiments were performed on 56 
outbread male rats, 180–220 g in weight. During 
the simulation of the pathology 8 animals died. 
The first experimental model of hepatopulmonary 
syndrome (HPS) was made by imposition of 
double ligature on common bile duct and its 
further dissection with a scalpel. [15] In the 
control group of animals № 1, common bile duct 
was separated from the tissue, but not dissec-
ted. Postoperative wound was sewed up com-
pletely in layers. In the 31st day after the surgery 
the animals were taken out of experiment 
under thiopental anaesthesia.
The second experimental HPS model was 
made by 8-week intragastric administration of 
oil solution CCl4 (400 g per 1 L), 0.5 ml per 100 g 
of body weight on the first day of the experiment, 
0.3 ml per 100 g on the third day of the expe-
riment and then every third day until the end 
of the experiment 0.3 ml per 100 g. A mixture 
of corn flour, lard and cholesterol and alcohol 
solution was added to the standard diet of the 
rats. The control group of animals № 2 was on 
a standard diet of the vivarium and was admi-
nistered intragastrically the equivalent amount 
of olive oil. [21].
Animal care and experiments were perfor-
med in accordance with the European Conven-
tion for the Protection of Animals Used for Ex-
perimental and Other Scientific Purposes [14].
Blood serum and bronchoalveolar lavage 
(BAL) were the subjects of the research.
Quantitative assessment of NO metabolites 
content was performed by evaluation of their 
amount, which included nitrite ions that were 
previously presented in the sample (NO2–) and 
also nitrate ions restored to nitrites (NO3–) [2]. 
Recovery was performed using zinc dust in 
acidic environment. Nitrites with sulphanilic 
acid underwent a reaction of diazotization, 
obtained diazotization solution of N-1 – nafty-
letylendiamin formed azo dye. Optical density 
of the obtained colour solution was evaluated 
by spectrophotometry at absorption maximum 
and wavelength 536 nm.
According to the evaluation results of cali-
bration solutions optical density (Y), calibration 
straight line was built and regressor was esti-
mated: Y=A+BX, Y is optical density of calibra-
tion solutions; X – concentration of calibration 
solutions, mmol/l; B – regression coefficient; 
A – intercept.
The concentration of NO metabolites in the 
studied sample was estimated by the equation: 
X1=(Y1–A)/B, Y1 is optical density of the studied 
sample.
Statistical analysis of the data received was 
conducted by standard methods of variation 
statistics using statistical software package. 
Results are presented as (M±m), M is mean 
value, m – standard error. Statistical signifi-
cance of the studied rates was determined by 
means of paired t-test.
Correlation analysis was performed be-
tween the data studied. Linear correlation coef-
ficient (r) and its significance (b) appropriately 
denoted in the tables (correlation matrices) 
were evaluated. If index r=0, link was consid-
ered to be lost, range 0–0,3 evidenced about 
weak correlation, index interval 0.3–0.7 demon-
strated medium link, and interval 0,7–1,0 proved 
a significant correlation interaction. The cor-
relation coefficient was significant at p<0.05.
Results and Discussion
The total content of nitric oxide metabolites 
(NO2–+NO3–) are presented in Table 1.
The total content of nitric oxide metabolites 
in blood serum of the rats of the experimental 
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group № 1 (on the 31st day after the common 
bile duct ligation) was significantly increased in 
3.9 times (p1<0,001) if compared with the con-
trol group № 1. In the rats of the 2nd experimen-
tal group (with carbon tetrachloride induced 
cirrhosis) the total content of nitric oxide me-
tabolites in blood serum also significantly in-
creased in 3.1 times (p1<0,001).
Comparison of nitric oxide metabolites 
content in blood serum and bronchoalveolar 
lavage, which directly indicated about the proc-
esses in lung tissue, was great importance. It 
was determined that NO production disorders 
took place unidirectionally towards the oxida-
tive stress flare. Thus, the total content of nitric 
oxide metabolites in BAL (Table 1) in the rats of 
the experimental group № 1 also significantly 
increased in 5,8 times (p1<0,001), and in the rats 
of the experimental group № 2 – in 4.5 times 
(p1<0,001).
The correlative analysis showed that, in 
simulation of hepatopulmonary syndrome by 
common bile duct ligation, total content of nitric 
oxide metabolites in blood serum had strong 
positive correlative link with the content of 
NO2–+NO3– in BAL (r=0,87) (p<0,01). In carbon 
tetrachloride induced cirrhosis (experimental 
mo del № 2) the total content of nitric oxide 
metabolites in blood serum also had a strong 
positive correlative relationship with the con-
tent of NO2–+NO3– in BAL (r=0,84) (p<0.01). This 
evidenced the unidirectionality of changes in 
nitroxydergic processes in blood and lungs in 
cases of hepatopulmonary syndrome of the 
applied models.
Probably, the synthesis of nitric oxide in 
cases of experimental hepatopulmonary syn-
drome increased due to the activation of induc-
ible NO-synthase under the influence of pro-
inflammatory cytokines and endotoxins, which 
caused increase in production of NO by liver 
Kupffer’s cells and alveolar macrophages. Our 
results coincide with the studies of other au-
thors. M. B. Fallon et al. defined and empha-
sized the role of NO in experimental model of 
liver cirrhosis, where overexpression of eNOS 
by pulmonary vessels caused increase in pro-
duction of endothelin-1 (ET-1) by cholangiocy-
tes, whereby expression of endothelin recep-
tors type B to ET-1 at pulmonary vessels and 
Table 1. nitric oxide metabolites content in blood serum and bronchoalveolar lavage  
in rats with experimental hepatopulmonary syndrome (M±m)
Experimental group Control group № 1 (n=12)
Experimental 
group № 1
(n=12)
Control group 
№ 2
(n=12)
Experimental 
group № 2
(n=12)
Blood serum
NO2–+NO3–, mcmol/L 36,7±6,0 143,4±14,8
p1<0,001
33,4±4,4 104,2±9,3
p1<0,001
p2<0,05
BAL
NO2–+NO3–, mcmol/L 14,1±3,2 81,7±7,6
p1<0,001
12,0±3,2 54,7±6,9
p1<0,001
p2<0,05
Legends: 
p1– significant difference if compared to the control animals; 
р2 – significant difference if compared to the affected animals.
Fig. 1. Comparison of nitric oxide metabolites content in blood serum and bronchoalveolar lavage (* – significant dif-
ference if compared to the control animals (p<0,001); # – significant difference if compared to the affected animals 
(p<0,05).
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synthesis of nitric oxide increased [16]. The 
level of NO in expired air increased in patients 
with HPS, and turned to normal in 3–12 months 
after liver transplantation. [19] Degano B. et al. 
in a similar study found out that concentration 
of NO in expired air in patients with liver cir-
rhosis was 3 times higher than that in the non-
cancer [12] By means of the method of flow 
cytofluorimetery that allows to differentiate 
alveolar and bronchial origin of NO, the main 
alveolar increase in formation of NO was de-
termined [13]. It was revealed that NO produc-
tion by alveoli can influence hemodynamic 
disturbances and changes in gas exchange in 
patients with liver cirrhosis. Thus, a close rela-
tionship between alveolar production of NO 
and hyperdynamic circulation type was defined 
[20]. Moreover, in experimental liver cirrhosis 
in rats, overexpression of both inducible and 
constitutional isoforms of NO-synthase in al-
veolar macrophages and lung endothelial cells 
was observed [22]. The further studies of NO 
showed that despite all mentioned above, re-
lationship of NO with portal hypertension, hy-
perdynamic circulation type and degree of liver 
damage is unclear. [17] In addition, other mo-
lecular mechanisms of vasodilation –nitric oxide 
independent: enzymatic formation of CO by 
increase in expression of heme-oxygenase-1, 
enzymatic formation of H2S and stimulation of 
calcium-activated potassium channels through 
endothelial derivative – hyperpolarization fac-
tor are described in the literature [8, 11].
Conclusions and further research 
1. So, in rats with experimental hepato-
pulmonary syndrome activation of nitroxydergic 
process by significant increase in nitric oxide 
metabolites in blood serum and bronchoalveolar 
lavage took place.
2. After studying the results of nitric oxide 
metabolites content in blood serum and bron-
choalveolar lavage, synchronous development 
of nitroxydergic processes on systemic and 
local levels and predominance of nitric oxide 
synthesis in lungs was determined.
In the future, pro-inflammatory cytokines 
rate in rats with experimental hepatopulmonary 
syndrome should be studied for more profound 
pathogenetic substantiation of nitroxydergic 
processes intensification.
 
Fig. 2. Comparison of increase in intensity of nitric oxide metabolites content in blood serum and bronchoalveolar lavage 
(NO2–+NO3– content in both control groups was equated to 100 %).
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